Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Short term Debt (2018 - 2020)

AC Immune (ACIU) reported Short term Debt of $336773.3 for Q3 2020, down 0.66% year-over-year from $338993.8 in Q4 2019, and up 1.09% on a QoQ basis from $333137.6 in Q2 2020.

AC Immune (ACIU) has 3 years of Short term Debt data on file, last reported at $336773.3 in Q3 2020.

  • Quarterly Short term Debt fell 0.66% year-over-year to $336773.3 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $336773.3 (down 0.66% YoY) and the FY2019 annual result came in at $656409.3, up 96.76% from the prior year.
  • Short term Debt grew to $336773.3 in Q3 2020 per ACIU's latest filing, from $333137.6 in the prior quarter.
  • Across five years, Short term Debt topped out at $658770.1 in Q4 2019 and bottomed at $328.11 in Q2 2019.
  • The 3-year median for Short term Debt is $335869.8 (2020), against an average of $334242.4.
  • Peak annual rise in Short term Debt reached 101430.97% in 2020, while the deepest fall reached 0.71% in 2020.
  • Tracing ACIU's Short term Debt over 3 years: stood at $333605.1 in 2018, then surged by 97.47% to $658770.1 in 2019, then slumped by 48.88% to $336773.3 in 2020.
  • Per Business Quant, the three latest ACIU Short term Debt figures stand at $336773.3 (Q3 2020), $333137.6 (Q2 2020), and $334966.3 (Q1 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 AC Immune 325.88 Mn 211.53 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2020 336,773.30
Jun 30, 2020 333,137.61
Mar 31, 2020 334,966.30
Dec 31, 2019 658,770.12
Sep 30, 2019 338,993.75
Jun 30, 2019 328.11
Mar 31, 2019 337,365.01
Dec 31, 2018 333,605.15